Combination vaccine safe and effective for infants
NEW YORK (Reuters Health) - A combination vaccine against diphtheria, tetanus, pertussis, polio and flu, which is routinely used in Canadian children, has been shown to be effective and well tolerated in a U.S. study.
The randomized trial was conducted to support U.S. licensure of the vaccine known as DTaP5-IPV-Hib, which incorporates diphtheria-tetanus-5-component acellular pertussis (DTaP5), inactivated poliovirus (IPV), and Haemophilus influenzae type B (Hib) vaccines.
Nearly 2000 infants were vaccinated at 2, 4, and 6 months of age, either with the DTaP5-IPV-Hib combination vaccine (Pentacel; Sanofi Pasteur Ltd., Toronto, Ontario) or with the DTaP5, IPV and Hib vaccines administered separately. Some babies in each group were also given fourth dose of DTaP5-IPV-Hib or of the DTaP5 and Hib vaccines as toddlers.
In the journal Pediatrics, Dr. Fernando A. Guerra of the San Antonio Metropolitan Health District in Texas and colleagues report that, compared with licensed vaccines, the combined vaccine was equally effective and produced similar or fewer reactions at the injection site and throughout the body.
“The current results are reassuring and consistent with safety surveillance data in Canada, where for the past decade, the combination vaccine has been the only DTaP-containing vaccine used among infants and toddlers,” the researchers conclude.
SOURCE: Pediatrics, January 2009.
--------------------------------------------------------------------------------------------Related Posts:
By Maggie Fox, Health and Science Editor WASHINGTON (Reuters) - An experimental malaria vaccine is the most promising yet, protecting up to 65 percent of infants from infection in two studies in Africa, researchers reported on Monday. Separate tests in Kenya and Tanzania showed GlaxoSmithKline’s vaccine called RTS,S could protect babies and toddlers from infection with malaria
Full Post: Glaxo malaria vaccine protects babies, children
--------------------------------------------------------------------------------------------
By Gene Emery BOSTON (Reuters) - A newer vaccine that targets the most common form of the polio virus works up to four times better than the conventional vaccine that tries to protect against all three types of the crippling disease, researchers said on Wednesday. The monovalent vaccine may help speed the fight to eradicate polio, U.S.
Full Post: Newer vaccine seen as better for polio hot spots
--------------------------------------------------------------------------------------------
By Amy Norton NEW YORK (Reuters Health) - Whooping cough may be known as a childhood disease, but adults should be aware that they can contract the infection too, researchers say. Whooping cough, known medically as pertussis, is a highly contagious respiratory infection that causes uncontrollable attacks of coughing and breathlessness. Before a vaccine became available, whooping
Full Post: Whooping cough affects adults too
--------------------------------------------------------------------------------------------
By Megan Rauscher NEW YORK (Reuters Health) - Even in an influenza season where there is not an optimal match between circulating strains of influenza and the strains contained in the influenza vaccine, the vaccine is likely to significantly protect young children, ages 6 to 59 months, against influenza, new research indicates. Influenza vaccine effectiveness has not
Full Post: Influenza vaccine effective in young children
--------------------------------------------------------------------------------------------
By C. Vidya Shankar, MD CHENNAI, India (Reuters Health) - HIV-positive infants are over 20 times more likely to develop tuberculosis than their HIV-negative counterparts, researchers from South Africa report in the current issue of Clinical Infectious Diseases. “The current status of TB amongst HIV-infected children is still very high,” Dr. Anneke Hesseling from Cape Town told
Full Post: Dual HIV/TB infection common in S. African infants